...Julie Brooks as EVP, general counsel and secretary, formerly EVP, general counsel and secretary at Conceptus Inc....

...Bayer completed its acquisition of Conceptus for $31 per share, or about $1.1 billion (see BioCentury...
...for $31 per share, or about $1.1 billion (see BioCentury, May 6 & May 13). Conceptus Inc....

...began its tender offer to acquire Conceptus for $31 per share, which Bayer says values Conceptus...
...about $1.1 billion. The offer expires at midnight on June 5 (see BioCentury, May 6). Conceptus Inc....

...Bayer says values Conceptus at about $1.1 billion. The price is a 20% premium to Conceptus'...
...of $25.90 on April 26, the last trading day prior to the announcement. Bayer gains Conceptus'...
...flexible inserts into the fallopian tubes. In 2012, Conceptus reported $141 million in net sales. Conceptus Inc....

...Women's health company Conceptus acquired from American Medical full rights to the Essure birth control system...
...purchase of all patents and IP associated with Ovion Inc. for $23.6 million in cash. Conceptus...
...tubes. American Medical acquired Ovion in 2005. American Medical Systems Holdings Inc. (NASDAQ:AMMD), Minnetonka, Minn. Conceptus Inc....

...Sciences Inc. (CALP), Hopkinton, Mass. Business: Microarrays Appointed: Kathryn Tunstall, former president and CEO of Conceptus Inc....

...Sciences Inc. (CALP), Hopkinton, Mass. Business: Microfluidics Appointed: Kathryn Tunstall, former president and CEO of Conceptus Inc....

...from the sale of Target shares in the open market. Target spawned its own company, Conceptus Inc....

...one program," he said. Another CGEN offspring, Target Therapeutics Inc., just spawned its own company, Conceptus...